Global Opioids Market Outlook To 2026: In-Depth Market Overview, Key Product Categories (Immediate-release/Short-acting, Extended-release/Long-acting, Codeine, Oxycodone, Hydrocodone, Fentanyl, Morphine, Hydroxymorphone, Oxymorphone, Propoxyphene, Methadone, Tapentadol, Buprenorphine), Application (Pain Relief, Cancer Pain, Post-operative Pain Management, Low Back Pain, Orthopedic, Anesthesia, Neuropathic Pain, Fibromyalgia, Cough Suppression, Diarrhoea Suppression, De-addiction), Regional Segmentation, Pricing Analysis, Pipeline Analysis, Competitive Dynamics, M&A Insights, Segment Forecast And Conclusion

$3,650.00$6,650.00

Clear
  • Report Description
  • Table of Content
  • Highlight
  • Research Methodology
  • Request Free Sample

The Opioids Market was valued at $xx.7Billion in 2018 and is forecast to grow at a modestxx.8 % CAGR between2018 and 2025, culminating in 2026 global sales of $xx.8Billion.

 

An Opioids is a class of drugs or medicine which are used in a human body through the nervous system to produce feelings of pleasure or to control the pain after the surgery. It is illegal if you don’t have any prescription. Opioids work through lowering the number of pains signals your body sends to your brain so it is also is known as a painkiller. Overall, it is fully semisynthetic, natural and manmade drugs. Some prescription medication such as morphine, fentanyl, oxycodone, codeine, methadone, are Opioids. Basically, these drugs are more used in anti-diarrheal and cough suppressants medicine and increasing of the geriatric population with the growth of healthcare is anticipated to propel the market in a constructive way. Due to the more no of surgery, trauma cases and road Injured cases will take lots of pain killer such as Opioids medicine. In the U.S there are 11% of adults having chronic pain and 26% of patients receiving Opioids for chronicnon-cancer pain. However, it will boost the market including healthcare in the form of profitability.

Opioids Market

 

Pricing Analysis

 

“Optimal Price Point (OPP) for Global Opioids”

 

Estimated Average product/ service cost – $ xx globally. However, with improving access and availability of options, OPP and range of acceptable Prices (RAP) are going to change. We at Ameri Research continuously track these prices with our proprietary pricing model.

 

Due to the wide array of products available in the market, pricing, positioning, and sales channel optimization play a vital role in the success of a product. On average, in the China Global Opioids materials are available at USD xxx- USD xxxx. However, high-end products are available at much higher prices. The prices in emerging countries and developed countries vary significantly due to the difference in purchasing power and availability of latest products.

 

Global Opioids Market by “Product Categories”

 

We have segmented the Global Opioids based on Product categories as Immediate-release/Short-acting, Extended-release/Long-acting, Codeine, Oxycodone, Hydrocodone, Fentanyl, Morphine, Hydroxymorphone, Oxymorphone, Propoxyphene, Methadone, Tapentadol, Buprenorphine.

 

We have observed that the rapid growth of Opioids followed by Extended-release/Long-acting with CAGR of xx.9% over the forecast period. It helps the body in the form of long-acting, sustained-release, and controlled-released drug product.

 

A dosage form that permits as a minimum dual reduction in dosage rate as related to that drug presented as an immediate-release (conventional) dosage form.

 

Global Opioids Market by “Application”

 

We have segmented the Global Opioids market based on Application is Pain Relief, Cancer Pain, Post-operative Pain Management, Low Back Pain, Orthopedic, Anesthesia, Neuropathic Pain, Fibromyalgia, Cough Suppression, Diarrhoea Suppression, De-addiction.

 

We have observed that Opioids market dominated worldwide by the Pain relief segment in the market with USD xx billion over the forecast period. Most people demand Anesthesia as an Opioids drug to reduce the pain and is expected to grow with CAGR 6.9% till 2026.

 

We have also observed the rapid growth of Cancer Pain in the market which expects to grow by shares during the forecast period. To get the instant release from cancer pain they used definite drugs for example Oxy Contin, which will boost the market share in the future.

 

Regional Segmentation

 

North America and U.S accounted for the maximum revenue share of over xx% in 2018 due to increased demand of Global Opioids materials followed by EU- Top 5 countries contribute $X.6 Billion in 2018 and expected to reach $x.5 Billion by 2026.

 

The rapid growth of health awareness and availability of Global Opioids materials option Extended-release/Long-acting and Pain reliefcreatean impact in developing countries for the demand for Instant Pain Release After surgery.

 

“Competitive Landscape”and “Merger & Acquisition Insights”

 

The key market participants Teh Seng Pharmaceutical Mfg. Co., Ltd., Endo Pharmaceuticals Inc., Teikoku Seiyaku Co., Ltd., Allergan, Pfizer Inc., Hisamitsu Pharmaceutical Co. Inc., GlaxoSmithKline plc., Mylan N.V., IBSA Institut Biochimque SA, Inc., Acorda Therapeutics.are few major players in Global Opioidsmarkets. TheGlobal Opioids market is fragmented with a large number of global & local players. Merger &Acquisitions, collaborations & new products launch are some of the major strategies adopted by key market players. Apart from this innovation& new product development are a major focus area for dominant companies.

 

Market Segmentation

 

Global Opioids Market by Product categories (Revenue, Million, 2018 – 2026)

  • Immediate-release/Short-acting
  • Extended-release/Long-acting
  • Codeine
  • Oxycodone
  • Hydrocodone
  • Fentanyl
  • Morphine
  • Hydroxymorphone
  • Oxymorphone
  • Propoxyphene
  • Methadone
  • Tapentadol
  • Buprenorphine

 

Global Opioids Market by Application Type (Revenue, Million, 2018 – 2026)

  • Pain Relief
  • Cancer Pain
  • Post-operative Pain Management
  • Low Back Pain
  • Orthopedic, Anesthesia
  • Neuropathic Pain
  • Fibromyalgia
  • Cough Suppression
  • Diarrhoea Suppression
  • De-addiction

 

 

Global Opioids Market Regional Outlook (Revenue, USD Million, 2018-2026)

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
  • Latin America
    • Brazil
    • Mexico
    • Columbia
  • Middle East and Africa
    • South Africa
    • Saudi Arabia

Global Opioids Market, Global Opioids Market Analytics, Global Opioids Market Share, Global Opioids Market Research, Global Opioids Market Forecast, Global Opioids Market Insight, Global Opioids Market Trend, Global Opioids Market Value, Global Opioids Market Size, Global Opioids Market Analysis, Global Opioids Market Survey, Global Opioids Market Research Report

Chapter 1 Methodology and Scope

  • Research Methodology
  • Research Scope & Assumptions
  • List of Data Sources

Chapter 2 Executive Summary

Chapter 3 Opioids Market Overview

  • Market Ecosystem
  • Key Stakeholders
  • Industry Trends & Analysis

Chapter 4 Opioids Trend Outlook

  • Market Overview
  • Market Segmentation
  • Market Size and Growth Prospects
  • Leading Brand Dynamics
  • Key Market Drivers
    • Expanding applications of Opioidss in various therapeutic conditions
    • Expanding target audience for the Opioids Market
    • Formulation of Opioidss switching from immediate to extended - release forms
  • Key Market Challenges
    • Stringent regulatory framework
    • Opioids abuse and dependency
  • Key Opportunities Prioritized
  • Industry Analysis - Porter’s
  • Opioids Market-PESTEL Analysis

Chapter 5: -Opioids Market by “Product Categories” (USD Million)

Opioids Market Landscape by Key Categories - 2018-2026
  • Immediate-release/Short-acting
    • Market Landscape Analysis, 2018-2026
  • Extended-release/Long-acting
    • Market Landscape Analysis, 2018-2026
  • Codeine
    • Market Landscape Analysis, 2018-2026
  • Oxycodone
    • Market Landscape Analysis, 2018-2026
  • Hydrocodone
    • Market Landscape Analysis, 2018-2026
  • Fentanyl
    • Market Landscape Analysis, 2018-2026
  • Morphine
    • Market Landscape Analysis, 2018-2026
  • Hydroxymorphone
    • Market Landscape Analysis, 2018-2026
  • Oxymorphone
    • Market Landscape Analysis, 2018-2026
  • Propoxyphene
    • Market Landscape Analysis, 2018-2026
  • Methadone
    • Market Landscape Analysis, 2018-2026
  • Tapentadol
    • Market Landscape Analysis, 2018-2026
  • Buprenorphine
    • Market Landscape Analysis, 2018-2026

Chapter 7: -Opioids Market by “Application” (USD Million)

Opioids Market Landscape by Application- 2018-2026
  • Pain Relief
    • Market Landscape Analysis, 2018-2026
  • Cancer Pain
    • Market Landscape Analysis, 2018-2026
  • Post-Operative Pain Management
    • Market Landscape Analysis, 2018-2026
  • Low- back pain
    • Market Landscape Analysis, 2018-2026
  • Orthopedic
    • Market Landscape Analysis, 2018-2026
  • Anesthesia
    • Market Landscape Analysis, 2018-2026
  • Neuropathic Pain
    • Market Landscape Analysis, 2018-2026
  • Fibromyalgia
    • Market Landscape Analysis, 2018-2026
  • Cough Suppression
    • Market Landscape Analysis, 2018-2026
  • Diarrhoea Suppression
    • Market Landscape Analysis, 2018-2026
  • De-addiction
    • Market Landscape Analysis, 2018-2026

Chapter 8: Regional Market Outlook

Opioids Market Landscape by Region- 2018
  • North America Market Landscape Analysis, 2018-2026 (USD Mn)
    • U.S. Market Landscape Analysis, 2018-2026
    • Canada Market Landscape Analysis-2018-2026
  • Europe Market Landscape Analysis, 2018-2026 (USD Mn)
    • UK Market Landscape Analysis, 2018-2026
    • Germany Market Landscape Analysis, 2018-2026
    • France Market Landscape Analysis, 2018-2026
    • Italy Market Landscape Analysis, 2018-2026
    • Spain Market Landscape Analysis, 2018-2026
  • Latin America Market Landscape Analysis, 2018-2026 (USD Mn)
    • Brazil Market Landscape Analysis, 2018-2026
    • Mexico Market Landscape Analysis, 2018-2026
    • Colombia Market Landscape Analysis, 2018-2026
  • Asia Pacific Market Landscape Analysis, 2018-2026 (USD Mn)
    • Japan Market Landscape Analysis, 2018-2026
    • China Market Landscape Analysis, 2018-2026
    • India Market Landscape Analysis, 2018-2026
  • Middle East & Africa Market Landscape Analysis, 2018-2026 (USD Mn)
    • Saudi Arabia Market Landscape Analysis, 2018-2026
    • South Africa Market Landscape Analysis, 2018-2026

Chapter 9: Pricing Analysis

Optimal Price Points (OPP), Indifference price points (IPP) and Range of Acceptable Prices and (RAP) of leading brands by Region- 2018
  • North America Pricing Analysis (OPP, IPP, and RAP - 2018)
    • U.S. Pricing Analysis-2018
    • Canada Pricing Analysis-2018
  • Europe Pricing Analysis (OPP, IPP, and RAP - 2018)
    • UK Pricing Analysis-2018
    • Germany Pricing Analysis-2018
    • France Pricing Analysis-2018
    • Italy Pricing Analysis-2018
    • Spain Pricing Analysis-2018
  • Latin America Pricing Analysis (OPP, IPP, and RAP - 2018)
    • Brazil Pricing Analysis-2018
    • Mexico Pricing Analysis-2018
    • Colombia Pricing Analysis-2018
  • Asia Pacific Pricing Analysis (OPP, IPP, and RAP - 2018)
    • Japan Pricing Analysis-2018
    • China Pricing Analysis-2018
    • India Pricing Analysis-2018
  • Middle East Pricing Analysis (OPP, IPP, and RAP - 2018)
    • Saudi Arabia Pricing Analysis-2018
    • South Africa Pricing Analysis-2018

Chapter 10: Opioids Pipeline Analysis

  • Executive Summary
  • Late Stage Pipeline analysis
  • Key R&D trends

Chapter 11: Opioids Merger &Acquisition Outlook

  • Factors driving M&A in Opioids market
  • Key trends and future outlook

Chapter 12: Competitive Landscape

  • Teh Seng Pharmaceutical Mfg. Co., Ltd
    • Company Overview
    • Financial Performance
    • Key Decision Maker
    • Product Pipeline
    • Strategic Initiative
  • Endo Pharmaceuticals Inc.
    • Company Overview
    • Financial Performance
    • Key Decision Maker
    • Product Pipeline
    • Strategic Initiative
  • Teikoku Seiyaku Co.
    • Company Overview
    • Financial Performance
    • Key Decision Maker
    • Product Pipeline
    • Strategic Initiative
  • Allergan
    • Company Overview
    • Financial Performance
    • Key Decision Maker
    • Product Pipeline
    • Strategic Initiative
  • Pfizer Inc.
    • Company Overview
    • Financial Performance
    • Key Decision Maker
    • Product Pipeline
    • Strategic Initiative
  • Hisamitsu Pharmaceutical Co. Inc.
    • Company Overview
    • Financial Performance
    • Key Decision Maker
    • Product Pipeline
    • Strategic Initiative
  • GlaxoSmithKline plc.
    • Company Overview
    • Financial Performance
    • Key Decision Maker
    • Product Pipeline
    • Strategic Initiative
 

List of Tables

 
  • TABLE 1 Opioids Market - Industry Snapshot & Key Buying Criteria, 2018 - 2026
  • TABLE 2 Global Opioids Market, 2018 – 2026
  • TABLE 3 Global Opioids Market Analysis by Product-2018
  • TABLE 4Global Opioids Market Analysis by Technology-2018
  • TABLE 5 Global Opioids Market Analysis by Application-2018
  • TABLE 7 Global Opioids Market Analysis by Geography-2018
  • TABLE 8Global Opioids Market Analysis by Leading Brands-2018
  • TABLE 9Opioids Market - Key market driver analysis
  • TABLE 10Opioids Market - Key market restraint analysis
  • TABLE 11North America Market Opioids Landscape Analysis, 2018-2026 (USD Mn)
  • TABLE 12U.S. Opioids Market Landscape Analysis, 2018-2026
  • TABLE 13Canada Opioids Market Landscape Analysis, 2018-2026
  • TABLE 14Europe Opioids Market Landscape Analysis, 2018-2026 (USD Mn)
  • TABLE 15U.K Opioids Market Landscape Analysis, 2018-2026
  • TABLE 16 Germany Opioids Market Landscape Analysis, 2018-2026
  • TABLE 17 France Opioids Market Landscape Analysis, 2018-2026
  • TABLE 18 Italy Opioids Market Landscape Analysis, 2018-2026
  • TABLE 19 Spain Opioids Market Landscape Analysis, 2018-2026
  • TABLE 20Latin America Opioids Market Landscape Analysis, 2018-2026 (USD Mn)
  • TABLE 21 Brazil Opioids Market Landscape Analysis, 2018-2026
  • TABLE 22 Mexico Opioids Market Landscape Analysis, 2018-2026
  • TABLE 20 Colombia Opioids Market Landscape Analysis, 2018-2026
  • TABLE 21 Asia Pacific Opioids Market Landscape Analysis, 2018-2026 (USD Mn)
  • TABLE 22Japan Opioids Market Landscape Analysis, 2018-2026
  • TABLE 23China Opioids Market Landscape Analysis, 2018-2026
  • TABLE 24 India Opioids Market Landscape Analysis, 2018-2026
  • TABLE 25North America Pricing Analysis
  • TABLE 26 North America Pricing Analysis (OPP, IPP, and RAP- 2018)
  • TABLE 27 U.S. Pricing Analysis-2018
  • TABLE 28 Canada Pricing Analysis-2018
  • TABLE 29 Europe Pricing Analysis (OPP, IPP, and RAP- 2018)
  • TABLE 30 U.K Pricing Analysis-2018
  • TABLE 31 Germany Pricing Analysis-2018
  • TABLE 32 France Pricing Analysis-2018
  • TABLE 33 Italy Pricing Analysis-2018
  • TABLE 34 Spain Pricing Analysis-2018
  • TABLE 35 Latin America Pricing Analysis (OPP, IPP, and RAP- 2018)
  • TABLE 36 Brazil Pricing Analysis-2018
  • TABLE 37 Mexico Pricing Analysis-2018
  • TABLE 38 Colombia Pricing Analysis-2018
  • TABLE 39 Asia Pacific Pricing Analysis (OPP, IPP, and RAP- 2018)
  • TABLE 40 Japan Pricing Analysis-2018
  • TABLE 41 China Pricing Analysis-2018
  • TABLE 42 India Pricing Analysis-2018
  • TABLE 43 Middle East Pricing Analysis (OPP, IPP, and RAP- 2018)
  • TABLE 44 Saudi Arabia Pricing Analysis-2018
  • TABLE 45 South Africa Pricing Analysis-2018
 

List of Figures

 
  • 1 Opioids Market Segmentation
  • 2 Market Size & Growth Prospects
  • 3 Leading Brand Dynamics
  • 4 Penetration & Growth Prospects
  • 5 Industry Analysis – Porter’s
  • 6 Opioids Market – PESTEL Analysis
  • 7Opioids Market Share by Product Type, 2018-2026
  • 8 Opioids Market Share by Cell Type, 2018-2026
  • 9 Opioids Market Share by Technique, 2018-2026
  • 10 Opioids Market Share by Application, 2018-2026
  • 11 Opioids Market Share by End-Use, 2018-2026
  • 12 Opioids Market Share by Region, 2018-2026

Key Insights Addressed:  

  • Defining market size from 2018 to 2026.
  • Estimating market growth till 2026 and consequence market forecast.
  • Identifying market drivers, restraints & future opportunities and allowing decision-maker with a range of possible outcomes and the probabilities that will occur for any choice of action.
  • Market segments and regions that will drive or lead market growth.
  • Defining Optimal Price Point (OPP) which will be accepted and recommended by maximum customers.
  • A bird’s-eye view of the competitive landscape and the key market players.
  • Key strategic growth driver adopted by market players. In-depth analysis of their strategies and implication on competition & growth.
    Key Findings:  
  • The global Opioid Market was valued at $xx.7 Billion in 2018 and is forecast to grow at a modest xx.8 % CAGR between 2018 and 2025, culminating in 2026 global sales of $xx.8 Billion.
  • An opioid is a class of drugs or medicine which are used in a human body through the nervous system to produce feelings of pleasure or to control the pain after the surgery. It is illegal if you don’t have any prescription. Opioid work through lowering the number of pains signals your body sends to your brain so it is also is known as a painkiller. Overall, it is fully semisynthetic, natural and manmade drugs
  • We have segmented the Global Opioid based on Product categories as Immediate-release/Short-acting, Extended-release/Long-acting, Codeine, Oxycodone, Hydrocodone, Fentanyl, Morphine, Hydroxymorphone, Oxymorphone, Propoxyphene, Methadone, Tapentadol, Buprenorphine.
  • We have segmented the Global Opioid market based on Application are Pain Relief, Cancer Pain, Post-operative Pain Management, Low Back Pain, Orthopedic, Anesthesia, Neuropathic Pain, Fibromyalgia, Cough Suppression, Diarrhoea Suppression, De-addiction.
  • The key market participants include Teh Seng Pharmaceutical Mfg. Co., Ltd., Endo Pharmaceuticals Inc., Teikoku Seiyaku Co., Ltd., Allergan, Pfizer Inc., Hisamitsu Pharmaceutical Co. Inc., GlaxoSmithKline plc., Mylan N.V., IBSA Institut Biochimque SA, Inc., Acorda Therapeutics.

Ameri Research implies a unique methodology of published information and primary research to bring key insights to customer decision making process. Our analytics model helps us to understand the structured and unstructured information from various sources. Key steps involves in the process are as below-

  1. Analyzing Published Information- Access to large pool of paid and unpaid published information via different sources and analyzing market trend.
  2. Setting Foundation- Input from analysis of secondary sources set our foundation to market analysis and helps in setting the scope for further research. Setting the scope involves Ameri Research proprietary statistical model, discussion with industry leaders, internal brainstorming, key discussion pointers from various forums etc.
  3. Need Gap Analysis- Defining the gap between our scope and availability of information.
  4. KOL Panel Discussion- Focused Group Discussion with a structured discussion guide to fine tune the gap and deriving the factors driving/restraining the market trend.
  5. Quantitative Research- Sampling large number of industry players, Education/Research Institutes, Government bodies, NGOs, Individual acclaimed researchers and conducting the primary interview with a structured questionnaire.
  6. Data Triangulation- We apply bottom-up demand approach or top-down estimation or a combined approach to triangulate the data points.
  7. Analyst Comment- Each of our analysts carries large pool of experience from domain perspective and add their value which is directional in nature
global-aesthetic-dermatology-market

To request a free sample copy of this report, please complete the form below verified and secure

We offer complete free customization that addresses client’s need. This includes insights from primary market research and a 60-minute free analyst consultation post report purchase.

This website is secure and your personal details are safe. Privacy policy

Description

The Opioids Market was valued at $xx.7Billion in 2018 and is forecast to grow at a modestxx.8 % CAGR between2018 and 2025, culminating in 2026 global sales of $xx.8Billion.

 

An Opioids is a class of drugs or medicine which are used in a human body through the nervous system to produce feelings of pleasure or to control the pain after the surgery. It is illegal if you don’t have any prescription. Opioids work through lowering the number of pains signals your body sends to your brain so it is also is known as a painkiller. Overall, it is fully semisynthetic, natural and manmade drugs. Some prescription medication such as morphine, fentanyl, oxycodone, codeine, methadone, are Opioids. Basically, these drugs are more used in anti-diarrheal and cough suppressants medicine and increasing of the geriatric population with the growth of healthcare is anticipated to propel the market in a constructive way. Due to the more no of surgery, trauma cases and road Injured cases will take lots of pain killer such as Opioids medicine. In the U.S there are 11% of adults having chronic pain and 26% of patients receiving Opioids for chronicnon-cancer pain. However, it will boost the market including healthcare in the form of profitability.

Opioids Market

 

Pricing Analysis

 

“Optimal Price Point (OPP) for Global Opioids”

 

Estimated Average product/ service cost – $ xx globally. However, with improving access and availability of options, OPP and range of acceptable Prices (RAP) are going to change. We at Ameri Research continuously track these prices with our proprietary pricing model.

 

Due to the wide array of products available in the market, pricing, positioning, and sales channel optimization play a vital role in the success of a product. On average, in the China Global Opioids materials are available at USD xxx- USD xxxx. However, high-end products are available at much higher prices. The prices in emerging countries and developed countries vary significantly due to the difference in purchasing power and availability of latest products.

 

Global Opioids Market by “Product Categories”

 

We have segmented the Global Opioids based on Product categories as Immediate-release/Short-acting, Extended-release/Long-acting, Codeine, Oxycodone, Hydrocodone, Fentanyl, Morphine, Hydroxymorphone, Oxymorphone, Propoxyphene, Methadone, Tapentadol, Buprenorphine.

 

We have observed that the rapid growth of Opioids followed by Extended-release/Long-acting with CAGR of xx.9% over the forecast period. It helps the body in the form of long-acting, sustained-release, and controlled-released drug product.

 

A dosage form that permits as a minimum dual reduction in dosage rate as related to that drug presented as an immediate-release (conventional) dosage form.

 

Global Opioids Market by “Application”

 

We have segmented the Global Opioids market based on Application is Pain Relief, Cancer Pain, Post-operative Pain Management, Low Back Pain, Orthopedic, Anesthesia, Neuropathic Pain, Fibromyalgia, Cough Suppression, Diarrhoea Suppression, De-addiction.

 

We have observed that Opioids market dominated worldwide by the Pain relief segment in the market with USD xx billion over the forecast period. Most people demand Anesthesia as an Opioids drug to reduce the pain and is expected to grow with CAGR 6.9% till 2026.

 

We have also observed the rapid growth of Cancer Pain in the market which expects to grow by shares during the forecast period. To get the instant release from cancer pain they used definite drugs for example Oxy Contin, which will boost the market share in the future.

 

Regional Segmentation

 

North America and U.S accounted for the maximum revenue share of over xx% in 2018 due to increased demand of Global Opioids materials followed by EU- Top 5 countries contribute $X.6 Billion in 2018 and expected to reach $x.5 Billion by 2026.

 

The rapid growth of health awareness and availability of Global Opioids materials option Extended-release/Long-acting and Pain reliefcreatean impact in developing countries for the demand for Instant Pain Release After surgery.

 

“Competitive Landscape”and “Merger & Acquisition Insights”

 

The key market participants Teh Seng Pharmaceutical Mfg. Co., Ltd., Endo Pharmaceuticals Inc., Teikoku Seiyaku Co., Ltd., Allergan, Pfizer Inc., Hisamitsu Pharmaceutical Co. Inc., GlaxoSmithKline plc., Mylan N.V., IBSA Institut Biochimque SA, Inc., Acorda Therapeutics.are few major players in Global Opioidsmarkets. TheGlobal Opioids market is fragmented with a large number of global & local players. Merger &Acquisitions, collaborations & new products launch are some of the major strategies adopted by key market players. Apart from this innovation& new product development are a major focus area for dominant companies.

 

Market Segmentation

 

Global Opioids Market by Product categories (Revenue, Million, 2018 – 2026)

  • Immediate-release/Short-acting
  • Extended-release/Long-acting
  • Codeine
  • Oxycodone
  • Hydrocodone
  • Fentanyl
  • Morphine
  • Hydroxymorphone
  • Oxymorphone
  • Propoxyphene
  • Methadone
  • Tapentadol
  • Buprenorphine

 

Global Opioids Market by Application Type (Revenue, Million, 2018 – 2026)

  • Pain Relief
  • Cancer Pain
  • Post-operative Pain Management
  • Low Back Pain
  • Orthopedic, Anesthesia
  • Neuropathic Pain
  • Fibromyalgia
  • Cough Suppression
  • Diarrhoea Suppression
  • De-addiction

 

 

Global Opioids Market Regional Outlook (Revenue, USD Million, 2018-2026)

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
  • Latin America
    • Brazil
    • Mexico
    • Columbia
  • Middle East and Africa
    • South Africa
    • Saudi Arabia

Global Opioids Market, Global Opioids Market Analytics, Global Opioids Market Share, Global Opioids Market Research, Global Opioids Market Forecast, Global Opioids Market Insight, Global Opioids Market Trend, Global Opioids Market Value, Global Opioids Market Size, Global Opioids Market Analysis, Global Opioids Market Survey, Global Opioids Market Research Report

Additional information

Price

Single User $3,650, Multiple User $4,650, Enterprise User $6,650